Gmed stock price currently

Currently, GMED stock price is outperforming the medical equipment peer group, thanks to diversified product lines and strong margins. Support zone sits firmly around $ Globus Medical, Inc. GMED reported first-quarter 2025 adjusted earnings per share (EPS) of 68 cents, which missed the Zacks Consensus Estimate by 8.1%. The figure increased 7.9% year over year. A company’s ROIC, or return on invested capital, shows how much operating profit it makes compared to the money it has raised (debt and equity). GMED stock price reflects investor confidence in niche medical technology innovation, with sector rotation favoring healthcare equities amid economic uncertainty. Projected earnings growth supports the stock’s valuation multiples.